NovoCure Ltd — Director's Dealing 2017

Jul 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-07-14

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-14	Ordinary Shares	M	354780	$0.38	Acquired	812362	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-14	Options to Buy Ordinary Shares	$0.38	M	354780	Disposed	2020-10-12	Ordinary Shares (354780)	Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.